Open AccessNew and emerging targeted therapies for cystic fibrosis
Author(s) -
Bradley S. Quon,
Steven M. Rowe
Publication year - 2016
Publication title -
bmj
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.831
H-Index - 429
ISSN - 1756-1833
DOI - 10.1136/bmj.i859
Subject(s) - ivacaftor , cystic fibrosis , cystic fibrosis transmembrane conductance regulator , medicine , genetic enhancement , disease , bioinformatics , loss function , gene , computational biology , biology , pathology , genetics , phenotype
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom